Rare case of nephrocalcinosis in a 14-year-old girl: Answers

[1] De Sanctis V., Soliman A., Fiscina B., Hypoparathyroidism: from diagnosis to treatment, Curr Opin Endocrinol Diabetes Obes, 19, pp. 435-442, (2012)

[2] Barakat A.Y., D'Albora J.B., Martin M.M., Jose P.A., Familial nephrosis, nerve deafness and hypoparathyroidism, J Pediatr, 91, pp. 61-64, (1977)

[3] Boyce A.M., Shawker T.H., Hill S.C., Choyke P.L., Hill M.C., James R., Yovetich N.A., Collins M.T., Gafni R.I., Ultrasound is Superior to Computed Tomography for Assessment of Medullary Nephrocalcinosis in Hypoparathyroidism, J Clin Endocrinol Metab, 98, pp. 989-994, (2013)

[4] Edvardsson V.O., Goldfarb D.S., Lieske J.C., Beara-Lasic L., Anglani F., Milliner D.S., Palsson R., Hereditary causes of kidney stones and chronic kidney disease, Pediatr Nephrol, 28, pp. 1923-1942, (2013)

[5] Sato K., Hasegawa Y., Nakae J., Nanao K., Takahashi I., Tajima T., Shinohara N., Fujieda K., Hydrochlorothiazide effectively reduces urinary calcium excretion in two Japanese patients with gain-of-function mutations of the calcium-sensing receptor gene, J Clin Endocrinol Metab, 87, pp. 3068-3073, (2002)

[6] Winer K.K., Wen Ko C., Reynolds J.C., Dowdy K., Keil M., Peterson D., Gerber L.H., McGarvey C., Cutler G.B., Long-term treatment of Hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1–34) versus calcitriol and calcium, J Clin Endocrinol Metab, 88, pp. 4214-4220, (2003)

[7] Levy I., Licht C., Daneman A., Sochett E., Harrington J., The impact of hypoparathyroidism treatment on the kidney in children: long-term retrospective follow-up study, J Clin Endocrinol Metab, 100, pp. 4106-4113, (2015)

[8] Neufeld M., Blizzard R.M., Polyglandular autoimmune diseases, Symposium on autoimmune aspects of endocrine disorders, pp. 357-365, (1980)

[9] Peterson P., Peltonen L., Autoimmune polyendocrinopathy syndrome type 1 (APS 1) and AIRE gene: new views on molecular basis of autoimmunity, J Autoimmun, 25, pp. 49-55, (2005)

[10] Halonen M., Eskelin P., Myhre A.G., Perheentupa J., Husebye E.S., Kampe O., Rorsman F., Peltonen L., Ulmanen I., Partanen J., AIRE mutation and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy—candidiasis—ectodermal dystrophy phenotype, J Clin Endocrinol Metab, 87, pp. 2568-2574, (2002)

[1] De Sanctis V., Soliman A., Fiscina B., Hypoparathyroidism: from diagnosis to treatment, Curr Opin Endocrinol Diabetes Obes, 19, pp. 435-442, (2012)

[2] Barakat A.Y., D'Albora J.B., Martin M.M., Jose P.A., Familial nephrosis, nerve deafness and hypoparathyroidism, J Pediatr, 91, pp. 61-64, (1977)

[3] Boyce A.M., Shawker T.H., Hill S.C., Choyke P.L., Hill M.C., James R., Yovetich N.A., Collins M.T., Gafni R.I., Ultrasound is Superior to Computed Tomography for Assessment of Medullary Nephrocalcinosis in Hypoparathyroidism, J Clin Endocrinol Metab, 98, pp. 989-994, (2013)

[4] Edvardsson V.O., Goldfarb D.S., Lieske J.C., Beara-Lasic L., Anglani F., Milliner D.S., Palsson R., Hereditary causes of kidney stones and chronic kidney disease, Pediatr Nephrol, 28, pp. 1923-1942, (2013)

[5] Sato K., Hasegawa Y., Nakae J., Nanao K., Takahashi I., Tajima T., Shinohara N., Fujieda K., Hydrochlorothiazide effectively reduces urinary calcium excretion in two Japanese patients with gain-of-function mutations of the calcium-sensing receptor gene, J Clin Endocrinol Metab, 87, pp. 3068-3073, (2002)

[6] Winer K.K., Wen Ko C., Reynolds J.C., Dowdy K., Keil M., Peterson D., Gerber L.H., McGarvey C., Cutler G.B., Long-term treatment of Hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1–34) versus calcitriol and calcium, J Clin Endocrinol Metab, 88, pp. 4214-4220, (2003)

[7] Levy I., Licht C., Daneman A., Sochett E., Harrington J., The impact of hypoparathyroidism treatment on the kidney in children: long-term retrospective follow-up study, J Clin Endocrinol Metab, 100, pp. 4106-4113, (2015)

[8] Neufeld M., Blizzard R.M., Polyglandular autoimmune diseases, Symposium on autoimmune aspects of endocrine disorders, pp. 357-365, (1980)

[9] Peterson P., Peltonen L., Autoimmune polyendocrinopathy syndrome type 1 (APS 1) and AIRE gene: new views on molecular basis of autoimmunity, J Autoimmun, 25, pp. 49-55, (2005)

[10] Halonen M., Eskelin P., Myhre A.G., Perheentupa J., Husebye E.S., Kampe O., Rorsman F., Peltonen L., Ulmanen I., Partanen J., AIRE mutation and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy—candidiasis—ectodermal dystrophy phenotype, J Clin Endocrinol Metab, 87, pp. 2568-2574, (2002)